Extended-release Pharmacotherapy for Opioid Use Disorder

NCT05164549 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

342

Enrollment

OTHER

Sponsor class

Conditions

Opiate Substitution Treatment

Interventions

DRUG: Buprenorphine Injectable Product
DRUG: Methadone
DRUG: Buprenorphine

Sponsor

King's College London

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]